Has Vincent Siebert, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,238 in general payments to Vincent Siebert, MD across 65 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vincent Siebert, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vincent Siebert, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vincent Siebert, MD

Interventional Cardiology · Naples, FLNPI 1477089514

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,654 of the $4,238 with a category attached, or 86.2%. 17 manufacturers reported payments, led by Boston Scientific at 26.2% of the total. Reporting peaked in 2024 at $1,555 and has fallen 51.6% since, to $753 in 2025. That places this record below the midpoint for interventional cardiology clinicians in FL, where the typical reported total is $7,973.

$4,238in general payments, 2019–2025

Across 65 payments — averaging $65.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$1K
Abbott$1K
Abiomed$368
Shockwave Medical, Inc$299
Teleflex LLC$287
Medtronic$266
plus $904 from 11 others

What the payments were for

Grants$2947%
Food & beverage$3,65486%
Education$2907%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	18	$1,112
Abbott	11	$1,002
Abiomed	3	$368
Shockwave Medical, Inc	6	$299
Teleflex LLC	2	$287
Medtronic	12	$266
Philips North America LLC	1	$143
Penumbra, Inc.	1	$141
Biotronik Inc.	2	$139
Johnson & Johnson	1	$139
E.r. Squibb & Sons, L.L.C.	1	$124
Heartflow, Inc.	2	$113
Cleerly, Inc.	1	$34
Esperion Therapeutics, Inc.	1	$20
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$18
AstraZeneca	1	$16
Pfizer	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GUIDELINER$287
ROTAPRO$175
AMPLATZER AMULET$171
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$168
QUADRA ASSURA$154
MitraClip$151
ONYX FRONTIER$150
AVVIGO Guidance System$146
(6575) Coronary Undivided$143
Indigo System$141
XARELTO$139
Perclose ProStyle$136
EnSite Precision Cardiac Mapping System$135
Impella$131
CAMZYOS$124
NAVITOR$124

How this compares

$4,238 in reported general payments places this provider in the 30th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida →

Medicare billing

Part B allowed, 2024

$58,940

Medicare patients

822

Services billed

1,228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	33	$294
Atorvastatin Calcium	20	$181
Metoprolol Succinate	15	$152
Rosuvastatin Calcium	11	$95
Ezetimibe	11	$22

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Naples

Roberto CubedduNaples$227K
Arthur LeeGainesville$1.8M
Santhosh MathewsBradenton$1.4M
Siddharth WayangankarJacksonville$1.2M
Patrick CambierTrinity$901K
Zahid AminOrlando$635K
Rohit AminPensacola$560K
Eduardo de MarchenaMiami$498K
Dominick AngiolilloJacksonville$387K
Miguel DiazHialeah$383K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →